Norplant Consensus Statement and Background Review

Overview

Journal Contraception

Publisher Elsevier

Specialty Reproductive Medicine

Date 1998 Apr 29

PMID 9554244

Citations 9

Authors

I S Fraser

A Tiitinen

B Affandi

V Brache

H B Croxatto

S Diaz

J Ginsburg

S Gu

P Holma

E Johansson

O Meirik

D R Mishell Jr

H A NASH

B von Schoultz

I Sivin

Affiliations

Soon will be listed here.

Abstract

This review has highlighted the attributes of a very important new method of contraception. The signatories to this document agree that, with the provision of appropriate information and instruction for the user, Norplant is a good contraceptive choice to be made available worldwide in family planning programs that have the resources for appropriate training and counseling. The signatories to this document are acting in their own personal capacity and not as representatives of any particular organization.

Citing Articles

Safety and Benefits of Contraceptives Implants: A Systematic Review.

Rocca M, Palumbo A, Visconti F, Carlo C Pharmaceuticals (Basel). 2021; 14(6).

PMID: 34201123 PMC: 8229462. DOI: 10.3390/ph14060548.

One-year incidence of low libido in women using levonorgestrel subdermal implant as contraception. Cohort study. Armenia, Colombia, 2014-2019.

Espitia De La Hoz F Rev Colomb Obstet Ginecol. 2021; 72(1):33-42.

PMID: 33878812 PMC: 8372765. DOI: 10.18597/rcog.3520.

Complications of Subcutaneous Contraception: A Review.

Ramdhan R, Simonds E, Wilson C, Loukas M, Oskouian R, Tubbs R Cureus. 2018; 10(1):e2132.

PMID: 29610715 PMC: 5878093. DOI: 10.7759/cureus.2132.

Importance of appropriate counselling in reducing early discontinuation of Norplant in a northern district of Bangladesh.

Huda F, Chowdhuri S, Sirajuddin M J Health Popul Nutr. 2014; 32(1):142-8.

PMID: 24847603 PMC: 4089082.

Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Backman T Drug Saf. 2004; 27(15):1185-204.

PMID: 15588115 DOI: 10.2165/00002018-200427150-00003.